Fig. 1

Overall survival (OS) and progression-free survival (PFS) of 215 patients with early-stage nasal-type extranodal natural killer/T-cell lymphoma (ENKTCL)
Overall survival (OS) and progression-free survival (PFS) of 215 patients with early-stage nasal-type extranodal natural killer/T-cell lymphoma (ENKTCL)